PCI

EuroPCR 2024 | Influence and Effect of CAD Physiopathological Patterns in the Safety and Efficacy of PCI

Coronary revascularization aims at improving coronary flow. However, after successful percutaneous coronary intervention (PCI) a significant number of patients might experience suboptimal coronary physiology. It has been observed that low fractional flow reserve (FFR) after PCI is associated to poor prognosis. Also, improved FFR after procedure directly correlates with improved angina symptoms.&nbsp; Pullback pressure during<a href="https://solaci.org/en/2024/05/17/europcr-2024-influence-and-effect-of-cad-physiopathological-patterns-in-the-safety-and-efficacy-of-pci/" title="Read more" >...</a>

Inteligencia artificial. Simposio internacional de cardiología intervencionista

Artificial Intelligence in Complex PCI Cases – 2nd International Symposium of Cardiology

The Latin American Society of Interventional Cardiology invites the whole community to take part in the 2nd International Symposium of Cardiology entitled “Artificial Intelligence in Complex PCI Cases”.&nbsp; The event will feature life case streaming and reputed international keynote speakers, and will be held on May 17 – 18, 2024, at Clinica Imagem’s Auditorium (Rua<a href="https://solaci.org/en/2024/04/30/artificial-intelligence-in-complex-pci-cases-2nd-international-symposium-of-cardiology/" title="Read more" >...</a>

PCI Evolution in Infiltrative Diseases

Infiltrative diseases (ID) consist of a heterogeneous series of genetic conditions that cause infiltration and extracellular deposits which alter the diverse systems and organs affected.&nbsp;&nbsp;&nbsp; Amyloidosis, sarcoidosis and hemochromatosis affect the heart, altering the myocardium and the conduction system.&nbsp; PCI is often used at present to treat heart disease, and some of these patients present<a href="https://solaci.org/en/2024/02/21/pci-evolution-in-infiltrative-diseases/" title="Read more" >...</a>

Disnea y oclusiones totales crónicas: un síntoma que podemos aliviar (o al menos intentarlo)

Contemporary Outcomes of CTO PCI in Europe: The ERCTO Registry

Roughly 20% or coronary angiographies show some form of chronic total occlusion (CTO), and this figure is twice as high for diabetic patients or those with cardiac failure and reduced ejection fraction (EF). CTO percutaneous intervention (PCI) has experienced a significant growth thanks to the development of new techniques and dedicated material. However, a considerable<a href="https://solaci.org/en/2024/02/08/contemporary-outcomes-of-cto-pci-in-europe-the-ercto-registry/" title="Read more" >...</a>

¿Es frecuente el uso de IVUS para guiar la ATC?

Use of IVUS in Complex PCI: Results according to Operator Experience

The use of ultravascular ultrasound (IVUS) to guide coronary angioplasty procedures (PCI) has been shown to reduce the risk of major adverse events in numerous randomized controlled studies, registries and meta-analysis.&nbsp; The current guidelines recommend the use of IVUS in left main disease and complex lesions. The proportion of complex PCI procedures has increased over<a href="https://solaci.org/en/2024/01/09/use-of-ivus-in-complex-pci-results-according-to-operator-experience/" title="Read more" >...</a>

ATC guiada por iFR ¿es igual en la DA que en el resto de los vasos?

iFR Guided PCI to the LAD: Same as for non-LAD Vessels?

iFR has been validated as a useful tool for intermediate lesion analysis, with the advantage of not requiring the use of drugs. On the other hand, its use for PCI outcome assessment has not yet been thoroughly looked into, even though there have been promising data.&nbsp; 24% of DEFINE PCI cases presented ≤0.89 iFR with<a href="https://solaci.org/en/2023/12/07/ifr-guided-pci-to-the-lad-same-as-for-non-lad-vessels/" title="Read more" >...</a>

La complejidad de la angioplastia puede definir el tiempo de doble antiagregación

Optimal Duration of DAPT with Oral Anticoagulation After PCI?: 1 Month vs. 3 Months

While the benefits of dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor are recognized, its primary complication is the occurrence of bleeding events, which negatively impact patient morbidity and mortality. Additionally, about 10% of patients undergoing percutaneous coronary intervention (PCI) are on oral anticoagulant therapy, which significantly increases the risk of bleeding when<a href="https://solaci.org/en/2023/11/23/optimal-duration-of-dapt-with-oral-anticoagulation-after-pci-1-month-vs-3-months/" title="Read more" >...</a>

AHA 2023

AHA 2023 | ORBITA-2: PCI vs. Placebo in Stable Angina for Symptom Reduction

In patients with stable chronic angina, percutaneous coronary intervention (PCI) is often conducted to relieve symptoms. However, there is still some uncertainty regarding whether PCI provides superior symptomatic relief compared with a placebo in patients not receiving anti-anginal medication. Researchers conducted a controlled and randomized study in which patients with stable angina discontinued all anti-anginal<a href="https://solaci.org/en/2023/11/14/aha-2023-orbita-2-pci-vs-placebo-in-stable-angina-for-symptom-reduction/" title="Read more" >...</a>

Top